Bisconti to Lead Drive for Patient Impact in Cancer Research
"We are excited to welcome Lynette to the Gateway team," said Alicia Stephenson, chair of the Gateway for Cancer Research board of directors. "Lynette brings the voice of cancer patients to our foundation. Her leadership and perspective on the needs of cancer patients and their families will help us better articulate why underwriting for clinical trials that can quickly reach the patient's bedside is so important."
Bisconti is passionate about changing today's health care paradigm to a patient-centered environment, advocating research to discover new and innovative (particularly nontoxic) treatments and providing all available treatment options to patients. She is a proponent of using integrative medicine, combining the best conventional treatments with science-based complementary therapies to enhance a patient's quality of life.
"Patient-centered cancer research adds a sense of immediacy and compassion that is often lost in today's clinical trials," said Bisconti. "People living with cancer want options. They want information and access to the latest treatments and therapies, including clinical trials.
"The traditional cancer research process has become blind to the immediate needs of cancer patients. It's a slow, faceless process that for a person with cancer today doesn't offer the hope that they're fervently seeking. Curing cancer will require that we examine every idea, every option from chemotherapy to nutrition. And every therapy that can extend survival or enhance quality of life must be made available to patients as soon as possible."
Bisconti served for several years as a member of the Patient Advisory Council at Cancer Treatment Centers of America and on the YMe Advocacy Network Steering Committee (now the Breast Cancer National Network of Strength). She also has worked as a team leader at the National Breast Cancer Coalition's Lobby Day on Capitol Hill, working with elected officials toward increased breast cancer research funding, improved and innovative research methods, and better access to quality care. Bisconti was honored as a 2004 Lifetime Television Breast Cancer Hero because of her unique fight with cancer and her work on behalf of cancer patients across the nation.
Founded in 1991, Gateway for Cancer Research was established by the Richard J. Stephenson family to identify and pursue new and promising clinical studies that offer the most progressive treatments, leveraging cutting-edge medical technologies and practices. Gateway was created after Mary Brown Stephenson lost her battle with cancer. The Stephenson family was frustrated by the lack of treatment options that might have helped save, extend, or improve the quality of Mrs. Stephenson's life.
Gateway has funded millions of dollars worth of research during its 17-year existence, with 99 cents of every dollar donated to the organization going directly to fund cancer research. Gateway is contributing vital information in the search for a cure to all types of cancer. Gateway-funded research encompasses the most innovative applications of conventional therapies (chemotherapy, radiation and surgery) and the best in science-based complementary medicine (nutrition, naturopathic medicine, psychoneuroimmunology, and spiritual support among others).
About Gateway for Cancer Research
Gateway for Cancer Research is a not-for-profit 501(c)(3) organization dedicated to curing cancer through funding innovative patient-centered clinical studies that impact those battling cancer. Thanks to generous underwriting of operational expenses, 99 cents of every dollar donated to Gateway goes directly to cancer research programs. For more information about Gateway for Cancer Research, please visit online at gatewayforcancerresearch.org.
SOURCE Gateway for Cancer Research
You May Also Like